% alzhub.org library filter
% Source: https://alzhub.org/research?author=Stomrud+E
% 54 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{ossenkoppele2025-40155777,
  author  = {Ossenkoppele, R. and Salvadó, G. and Janelidze, S. and Pichet Binette, A. and Bali, D. and Karlsson, L. and Palmqvist, S. and Mattsson-Carlgren, N. and Stomrud, E. and Therriault, J. and Rahmouni, N. and Rosa-Neto, P. and others},
  title   = {{Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials}},
  journal = {Nature Aging},
  year    = {2025},
  doi     = {10.1038/s43587-025-00835-z},
  pmid    = {40155777},
  url     = {https://doi.org/10.1038/s43587-025-00835-z}
}

@article{mattssoncarlgren2023-36745413,
  author  = {Mattsson-Carlgren, N. and Salvadó, G. and Ashton, N. J. and Tideman, P. and Stomrud, E. and Zetterberg, H. and Ossenkoppele, R. and Betthauser, T. J. and others},
  title   = {{Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers}},
  journal = {JAMA neurology},
  year    = {2023},
  doi     = {10.1001/jamaneurol.2022.5272},
  pmid    = {36745413},
  url     = {https://doi.org/10.1001/jamaneurol.2022.5272}
}

@article{pereira2021-34259835,
  author  = {Pereira, J. B. and Janelidze, S. and Smith, R. and Mattsson-Carlgren, N. and Palmqvist, S. and Teunissen, C. E. and Zetterberg, H. and Stomrud, E. and others},
  title   = {{Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2021},
  doi     = {10.1093/brain/awab223},
  pmid    = {34259835},
  url     = {https://doi.org/10.1093/brain/awab223}
}

@article{mattssoncarlgren2024-38048096,
  author  = {Mattsson-Carlgren, N. and Collij, L. E. and Stomrud, E. and Pichet Binette, A. and Ossenkoppele, R. and Smith, R. and Karlsson, L. and Lantero-Rodriguez, J. and Snellman, A. and Strandberg, O. and Palmqvist, S. and Ashton, N. J. and others},
  title   = {{Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies}},
  journal = {JAMA Neurology},
  year    = {2024},
  doi     = {10.1001/jamaneurol.2023.4596},
  pmid    = {38048096},
  url     = {https://doi.org/10.1001/jamaneurol.2023.4596}
}

@article{palmqvist2020-32722745,
  author  = {Palmqvist, S. and Janelidze, S. and Quiroz, Y. T. and Zetterberg, H. and Lopera, F. and Stomrud, E. and Su, Y. and Chen, Y. and others},
  title   = {{Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders}},
  journal = {JAMA},
  year    = {2020},
  doi     = {10.1001/jama.2020.12134},
  pmid    = {32722745},
  url     = {https://doi.org/10.1001/jama.2020.12134}
}

@article{ossenkoppele2022-36357681,
  author  = {Ossenkoppele, R. and Pichet Binette, A. and Groot, C. and Smith, R. and Strandberg, O. and Palmqvist, S. and Stomrud, E. and Tideman, P. and others},
  title   = {{Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline}},
  journal = {Nature medicine},
  year    = {2022},
  doi     = {10.1038/s41591-022-02049-x},
  pmid    = {36357681},
  url     = {https://doi.org/10.1038/s41591-022-02049-x}
}

@article{janelidze2021-33165506,
  author  = {Janelidze, S. and Berron, D. and Smith, R. and Strandberg, O. and Proctor, N. K. and Dage, J. L. and Stomrud, E. and Palmqvist, S. and others},
  title   = {{Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2021},
  doi     = {10.1001/jamaneurol.2020.4201},
  pmid    = {33165506},
  url     = {https://doi.org/10.1001/jamaneurol.2020.4201}
}

@article{janelidze2020-32246036,
  author  = {Janelidze, S. and Stomrud, E. and Smith, R. and Palmqvist, S. and Mattsson, N. and Airey, D. C. and Proctor, N. K. and Chai, X. and others},
  title   = {{Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease}},
  journal = {Nature communications},
  year    = {2020},
  doi     = {10.1038/s41467-020-15436-0},
  pmid    = {32246036},
  url     = {https://doi.org/10.1038/s41467-020-15436-0}
}

@article{mattsson2016-27694257,
  author  = {Mattsson, N. and Zetterberg, H. and Janelidze, S. and Insel, P. S. and Andreasson, U. and Stomrud, E. and Palmqvist, S. and Baker, D. and others},
  title   = {{Plasma tau in Alzheimer disease}},
  journal = {Neurology},
  year    = {2016},
  doi     = {10.1212/wnl.0000000000003246},
  pmid    = {27694257},
  url     = {https://doi.org/10.1212/wnl.0000000000003246}
}

@article{janelidze2018-30054439,
  author  = {Janelidze, S. and Mattsson, N. and Stomrud, E. and Lindberg, O. and Palmqvist, S. and Zetterberg, H. and Blennow, K. and Hansson, O.},
  title   = {{CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease}},
  journal = {Neurology},
  year    = {2018},
  doi     = {10.1212/wnl.0000000000006082},
  pmid    = {30054439},
  url     = {https://doi.org/10.1212/wnl.0000000000006082}
}

@article{salvado2025-40952756,
  author  = {Salvadó, G. and Janelidze, S. and Bali, D. and Dolado, A. O. and Therriault, J. and Brum, W. S. and Pichet Binette, A. and Stomrud, E. and Mattsson-Carlgren, N. and Palmqvist, S. and Coomans, E. M. and Teunissen, C. E. and others},
  title   = {{Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease}},
  journal = {JAMA Neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.3217},
  pmid    = {40952756},
  url     = {https://doi.org/10.1001/jamaneurol.2025.3217}
}

@article{nilsson2024-38325331,
  author  = {Nilsson, J. and Pichet Binette, A. and Palmqvist, S. and Brum, W. S. and Janelidze, S. and Ashton, N. J. and Spotorno, N. and Stomrud, E. and others},
  title   = {{Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases}},
  journal = {Brain : a journal of neurology},
  year    = {2024},
  doi     = {10.1093/brain/awae032},
  pmid    = {38325331},
  url     = {https://doi.org/10.1093/brain/awae032}
}

@article{cicognola2025-39817469,
  author  = {Cicognola, C. and Salvadó, G. and Smith, R. and Palmqvist, S. and Stomrud, E. and Betthauser, T. J. and Johnson, S. C. and Janelidze, S. and others},
  title   = {{APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-β}},
  journal = {Brain : a journal of neurology},
  year    = {2025},
  doi     = {10.1093/brain/awaf016},
  pmid    = {39817469},
  url     = {https://doi.org/10.1093/brain/awaf016}
}

@article{palmqvist2019-31233127,
  author  = {Palmqvist, S. and Janelidze, S. and Stomrud, E. and Zetterberg, H. and Karl, J. and Zink, K. and Bittner, T. and Mattsson, N. and others},
  title   = {{Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2019.1632},
  pmid    = {31233127},
  url     = {https://doi.org/10.1001/jamaneurol.2019.1632}
}

@article{palmqvist2021-34031605,
  author  = {Palmqvist, S. and Tideman, P. and Cullen, N. and Zetterberg, H. and Blennow, K. and {Alzheimer’s Disease Neuroimaging Initiative} and Dage, J. L. and Stomrud, E. and others},
  title   = {{Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures}},
  journal = {Nature medicine},
  year    = {2021},
  doi     = {10.1038/s41591-021-01348-z},
  pmid    = {34031605},
  url     = {https://doi.org/10.1038/s41591-021-01348-z}
}

@article{blennow2019-31836810,
  author  = {Blennow, K. and Shaw, L. M. and Stomrud, E. and Mattsson, N. and Toledo, J. B. and Buck, K. and Wahl, S. and Eichenlaub, U. and others},
  title   = {{Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Aβ(1-42), pTau and tTau CSF immunoassays}},
  journal = {Scientific reports},
  year    = {2019},
  doi     = {10.1038/s41598-019-54204-z},
  pmid    = {31836810},
  url     = {https://doi.org/10.1038/s41598-019-54204-z}
}

@article{pereira2021-34077494,
  author  = {Pereira, J. B. and Janelidze, S. and Stomrud, E. and Palmqvist, S. and van Westen, D. and Dage, J. L. and Mattsson-Carlgren, N. and Hansson, O.},
  title   = {{Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects}},
  journal = {Brain : a journal of neurology},
  year    = {2021},
  doi     = {10.1093/brain/awab163},
  pmid    = {34077494},
  url     = {https://doi.org/10.1093/brain/awab163}
}

@article{groot2023-36084009,
  author  = {Groot, C. and Smith, R. and Stomrud, E. and Binette, A. P. and Leuzy, A. and Wuestefeld, A. and Wisse, L. E. M. and Palmqvist, S. and others},
  title   = {{Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals}},
  journal = {Brain : a journal of neurology},
  year    = {2023},
  doi     = {10.1093/brain/awac329},
  pmid    = {36084009},
  url     = {https://doi.org/10.1093/brain/awac329}
}

@article{nagga2018-29196581,
  author  = {Nägga, K. and Gustavsson, A. M. and Stomrud, E. and Lindqvist, D. and van Westen, D. and Blennow, K. and Zetterberg, H. and Melander, O. and others},
  title   = {{Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later}},
  journal = {Neurology},
  year    = {2018},
  doi     = {10.1212/wnl.0000000000004749},
  pmid    = {29196581},
  url     = {https://doi.org/10.1212/wnl.0000000000004749}
}

@article{groot2024-38857029,
  author  = {Groot, C. and Smith, R. and Collij, L. E. and Mastenbroek, S. E. and Stomrud, E. and Binette, A. P. and Leuzy, A. and Palmqvist, S. and others},
  title   = {{Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment}},
  journal = {JAMA neurology},
  year    = {2024},
  doi     = {10.1001/jamaneurol.2024.1612},
  pmid    = {38857029},
  url     = {https://doi.org/10.1001/jamaneurol.2024.1612}
}

@article{salvado2026-42189519,
  author  = {Salvadó, G. and Horie, K. and Barthélemy, N. R. and Schindler, S. E. and Janelidze, S. and Orduña Dolado, A. and Bali, D. and Perrin, R. J. and Morris, J. C. and Benzinger, T. L. S. and Gordon, B. A. and Stomrud, E. and others},
  title   = {{Plasma eMTBR-tau243 and \%p-tau217 for Biological Staging of Alzheimer Disease}},
  journal = {JAMA Neurology},
  year    = {2026},
  doi     = {10.1001/jamaneurol.2026.1405},
  pmid    = {42189519},
  url     = {https://doi.org/10.1001/jamaneurol.2026.1405}
}

@article{hansson2018-29499171,
  author  = {Hansson, O. and Seibyl, J. and Stomrud, E. and Zetterberg, H. and Trojanowski, J. Q. and Bittner, T. and Lifke, V. and Corradini, V. and others},
  title   = {{CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2018},
  doi     = {10.1016/j.jalz.2018.01.010},
  pmid    = {29499171},
  url     = {https://doi.org/10.1016/j.jalz.2018.01.010}
}

@article{mattsson2019-31314895,
  author  = {Mattsson, N. and Palmqvist, S. and Stomrud, E. and Vogel, J. and Hansson, O.},
  title   = {{Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2019.2214},
  pmid    = {31314895},
  url     = {https://doi.org/10.1001/jamaneurol.2019.2214}
}

@article{mattssoncarlgren2020-32398359,
  author  = {Mattsson-Carlgren, N. and Leuzy, A. and Janelidze, S. and Palmqvist, S. and Stomrud, E. and Strandberg, O. and Smith, R. and Hansson, O.},
  title   = {{The implications of different approaches to define AT(N) in Alzheimer disease}},
  journal = {Neurology},
  year    = {2020},
  doi     = {10.1212/wnl.0000000000009485},
  pmid    = {32398359},
  url     = {https://doi.org/10.1212/wnl.0000000000009485}
}

@article{gertje2023-36882326,
  author  = {Gertje, E. C. and Janelidze, S. and van Westen, D. and Cullen, N. and Stomrud, E. and Palmqvist, S. and Hansson, O. and Mattsson-Carlgren, N.},
  title   = {{Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000207113},
  pmid    = {36882326},
  url     = {https://doi.org/10.1212/wnl.0000000000207113}
}

@article{cullen2021-37117993,
  author  = {Cullen, N. C. and Leuzy, A. and Palmqvist, S. and Janelidze, S. and Stomrud, E. and Pesini, P. and Sarasa, L. and Allué, J. A. and others},
  title   = {{Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations}},
  journal = {Nature aging},
  year    = {2021},
  doi     = {10.1038/s43587-020-00003-5},
  pmid    = {37117993},
  url     = {https://doi.org/10.1038/s43587-020-00003-5}
}

@article{tangen2022-36028328,
  author  = {Tangen, G. G. and Nilsson, M. H. and Stomrud, E. and Palmqvist, S. and Hansson, O.},
  title   = {{Spatial Navigation and Its Association With Biomarkers and Future Dementia in Memory Clinic Patients Without Dementia}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000201106},
  pmid    = {36028328},
  url     = {https://doi.org/10.1212/wnl.0000000000201106}
}

@article{janelidze2016-27241045,
  author  = {Janelidze, S. and Stomrud, E. and Palmqvist, S. and Zetterberg, H. and van Westen, D. and Jeromin, A. and Song, L. and Hanlon, D. and others},
  title   = {{Plasma β-amyloid in Alzheimer's disease and vascular disease}},
  journal = {Scientific reports},
  year    = {2016},
  doi     = {10.1038/srep26801},
  pmid    = {27241045},
  url     = {https://doi.org/10.1038/srep26801}
}

@article{palmqvist2025-40205199,
  author  = {Palmqvist, S. and Warmenhoven, N. and Anastasi, F. and Pilotto, A. and Janelidze, S. and Tideman, P. and Stomrud, E. and Mattsson-Carlgren, N. and others},
  title   = {{Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform}},
  journal = {Nature medicine},
  year    = {2025},
  doi     = {10.1038/s41591-025-03622-w},
  pmid    = {40205199},
  url     = {https://doi.org/10.1038/s41591-025-03622-w}
}

@article{leuzy2021-34493616,
  author  = {Leuzy, A. and Janelidze, S. and Mattsson-Carlgren, N. and Palmqvist, S. and Jacobs, D. and Cicognola, C. and Stomrud, E. and Vanmechelen, E. and others},
  title   = {{Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays}},
  journal = {Neurology},
  year    = {2021},
  doi     = {10.1212/wnl.0000000000012727},
  pmid    = {34493616},
  url     = {https://doi.org/10.1212/wnl.0000000000012727}
}

@article{mattssoncarlgren2021-33949133,
  author  = {Mattsson-Carlgren, N. and Janelidze, S. and Bateman, R. J. and Smith, R. and Stomrud, E. and Serrano, G. E. and Reiman, E. M. and Palmqvist, S. and others},
  title   = {{Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau}},
  journal = {EMBO molecular medicine},
  year    = {2021},
  doi     = {10.15252/emmm.202114022},
  pmid    = {33949133},
  url     = {https://doi.org/10.15252/emmm.202114022}
}

@article{janelidze2016-27042676,
  author  = {Janelidze, S. and Zetterberg, H. and Mattsson, N. and Palmqvist, S. and Vanderstichele, H. and Lindberg, O. and van Westen, D. and Stomrud, E. and others},
  title   = {{CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease}},
  journal = {Annals of clinical and translational neurology},
  year    = {2016},
  doi     = {10.1002/acn3.274},
  pmid    = {27042676},
  url     = {https://doi.org/10.1002/acn3.274}
}

@article{pereira2022-37118533,
  author  = {Pereira, J. B. and Janelidze, S. and Strandberg, O. and Whelan, C. D. and Zetterberg, H. and Blennow, K. and Palmqvist, S. and Stomrud, E. and others},
  title   = {{Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer's disease pathology}},
  journal = {Nature aging},
  year    = {2022},
  doi     = {10.1038/s43587-022-00310-z},
  pmid    = {37118533},
  url     = {https://doi.org/10.1038/s43587-022-00310-z}
}

@article{tideman2022-35022305,
  author  = {Tideman, P. and Stomrud, E. and Leuzy, A. and Mattsson-Carlgren, N. and Palmqvist, S. and Hansson, O. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000013299},
  pmid    = {35022305},
  url     = {https://doi.org/10.1212/wnl.0000000000013299}
}

@article{glans2023-36224029,
  author  = {Glans, I. and Sonestedt, E. and Nägga, K. and Gustavsson, A. M. and González-Padilla, E. and Borne, Y. and Stomrud, E. and Melander, O. and others},
  title   = {{Association Between Dietary Habits in Midlife With Dementia Incidence Over a 20-Year Period}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000201336},
  pmid    = {36224029},
  url     = {https://doi.org/10.1212/wnl.0000000000201336}
}

@article{ossenkoppele2021-34254442,
  author  = {Ossenkoppele, R. and Reimand, J. and Smith, R. and Leuzy, A. and Strandberg, O. and Palmqvist, S. and Stomrud, E. and Zetterberg, H. and others},
  title   = {{Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkers}},
  journal = {EMBO molecular medicine},
  year    = {2021},
  doi     = {10.15252/emmm.202114398},
  pmid    = {34254442},
  url     = {https://doi.org/10.15252/emmm.202114398}
}

@article{palmqvist2023-35950735,
  author  = {Palmqvist, S. and Stomrud, E. and Cullen, N. and Janelidze, S. and Manuilova, E. and Jethwa, A. and Bittner, T. and Eichenlaub, U. and others},
  title   = {{An accurate fully automated panel of plasma biomarkers for Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2023},
  doi     = {10.1002/alz.12751},
  pmid    = {35950735},
  url     = {https://doi.org/10.1002/alz.12751}
}

@article{palmqvist2019-31709776,
  author  = {Palmqvist, S. and Insel, P. S. and Stomrud, E. and Janelidze, S. and Zetterberg, H. and Brix, B. and Eichenlaub, U. and Dage, J. L. and others},
  title   = {{Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease}},
  journal = {EMBO molecular medicine},
  year    = {2019},
  doi     = {10.15252/emmm.201911170},
  pmid    = {31709776},
  url     = {https://doi.org/10.15252/emmm.201911170}
}

@article{whelan2019-31694701,
  author  = {Whelan, C. D. and Mattsson, N. and Nagle, M. W. and Vijayaraghavan, S. and Hyde, C. and Janelidze, S. and Stomrud, E. and Lee, J. and others},
  title   = {{Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease}},
  journal = {Acta neuropathologica communications},
  year    = {2019},
  doi     = {10.1186/s40478-019-0795-2},
  pmid    = {31694701},
  url     = {https://doi.org/10.1186/s40478-019-0795-2}
}

@article{cullen2022-34937781,
  author  = {Cullen, N. and Janelidze, S. and Palmqvist, S. and Stomrud, E. and Mattsson-Carlgren, N. and Hansson, O. and {Alzheimer’s Disease Neuroimaging Initiative}},
  title   = {{Association of CSF Aβ38 Levels With Risk of Alzheimer Disease-Related Decline}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000013228},
  pmid    = {34937781},
  url     = {https://doi.org/10.1212/wnl.0000000000013228}
}

@article{barthelemy2023-37117788,
  author  = {Barthélemy, N. R. and Saef, B. and Li, Y. and Gordon, B. A. and He, Y. and Horie, K. and Stomrud, E. and Salvadó, G. and others},
  title   = {{CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease}},
  journal = {Nature aging},
  year    = {2023},
  doi     = {10.1038/s43587-023-00380-7},
  pmid    = {37117788},
  url     = {https://doi.org/10.1038/s43587-023-00380-7}
}

@article{ayton2023-36357168,
  author  = {Ayton, S. and Janelidze, S. and Kalinowski, P. and Palmqvist, S. and Belaidi, A. A. and Stomrud, E. and Roberts, A. and Roberts, B. and others},
  title   = {{CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers}},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  year    = {2023},
  doi     = {10.1136/jnnp-2022-330052},
  pmid    = {36357168},
  url     = {https://doi.org/10.1136/jnnp-2022-330052}
}

@article{stomrud2010-20142530,
  author  = {Stomrud, E. and Hansson, O. and Zetterberg, H. and Blennow, K. and Minthon, L. and Londos, E.},
  title   = {{Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults}},
  journal = {Archives of neurology},
  year    = {2010},
  doi     = {10.1001/archneurol.2009.316},
  pmid    = {20142530},
  url     = {https://doi.org/10.1001/archneurol.2009.316}
}

@article{berron2024-38867417,
  author  = {Berron, D. and Olsson, E. and Andersson, F. and Janelidze, S. and Tideman, P. and Düzel, E. and Palmqvist, S. and Stomrud, E. and others},
  title   = {{Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2024},
  doi     = {10.1002/alz.13919},
  pmid    = {38867417},
  url     = {https://doi.org/10.1002/alz.13919}
}

@article{spotorno2020-32330946,
  author  = {Spotorno, N. and Acosta-Cabronero, J. and Stomrud, E. and Lampinen, B. and Strandberg, O. T. and van Westen, D. and Hansson, O.},
  title   = {{Relationship between cortical iron and tau aggregation in Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2020},
  doi     = {10.1093/brain/awaa089},
  pmid    = {32330946},
  url     = {https://doi.org/10.1093/brain/awaa089}
}

@article{ordunadolado2024-38909218,
  author  = {Orduña Dolado, A. and Stomrud, E. and Ashton, N. J. and Nilsson, J. and Quijano-Rubio, C. and Jethwa, A. and Brum, W. S. and Brinkmalm Westman, A. and others},
  title   = {{Effects of time of the day at sampling on CSF and plasma levels of Alzheimer' disease biomarkers}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01503-x},
  pmid    = {38909218},
  url     = {https://doi.org/10.1186/s13195-024-01503-x}
}

@article{cullen2021-34117234,
  author  = {Cullen, N. C. and Leuzy, A. and Janelidze, S. and Palmqvist, S. and Svenningsson, A. L. and Stomrud, E. and Dage, J. L. and Mattsson-Carlgren, N. and others},
  title   = {{Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations}},
  journal = {Nature communications},
  year    = {2021},
  doi     = {10.1038/s41467-021-23746-0},
  pmid    = {34117234},
  url     = {https://doi.org/10.1038/s41467-021-23746-0}
}

@article{pichetbinette2023-36152307,
  author  = {Pichet Binette, A. and Janelidze, S. and Cullen, N. and Dage, J. L. and Bateman, R. J. and Zetterberg, H. and Blennow, K. and Stomrud, E. and others},
  title   = {{Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2023},
  doi     = {10.1002/alz.12787},
  pmid    = {36152307},
  url     = {https://doi.org/10.1002/alz.12787}
}

@article{janelidze2022-34151519,
  author  = {Janelidze, S. and Palmqvist, S. and Leuzy, A. and Stomrud, E. and Verberk, I. M. W. and Zetterberg, H. and Ashton, N. J. and Pesini, P. and others},
  title   = {{Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p-tau}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2022},
  doi     = {10.1002/alz.12395},
  pmid    = {34151519},
  url     = {https://doi.org/10.1002/alz.12395}
}

@article{zheng2024-37837382,
  author  = {Zheng, L. and Rubinski, A. and Denecke, J. and Luan, Y. and Smith, R. and Strandberg, O. and Stomrud, E. and Ossenkoppele, R. and others},
  title   = {{Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease}},
  journal = {Annals of neurology},
  year    = {2024},
  doi     = {10.1002/ana.26818},
  pmid    = {37837382},
  url     = {https://doi.org/10.1002/ana.26818}
}

@article{ayton2021-32882319,
  author  = {Ayton, S. and Janelidze, S. and Roberts, B. and Palmqvist, S. and Kalinowski, P. and Diouf, I. and Belaidi, A. A. and Stomrud, E. and others},
  title   = {{Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE ε4, sex and age}},
  journal = {Progress in neurobiology},
  year    = {2021},
  doi     = {10.1016/j.pneurobio.2020.101904},
  pmid    = {32882319},
  url     = {https://doi.org/10.1016/j.pneurobio.2020.101904}
}

@article{kumar2022-35641311,
  author  = {Kumar, A. and Janelidze, S. and Stomrud, E. and Palmqvist, S. and Hansson, O. and Mattsson-Carlgren, N. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{β-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000200605},
  pmid    = {35641311},
  url     = {https://doi.org/10.1212/wnl.0000000000200605}
}

@article{pereira2021-33279949,
  author  = {Pereira, J. B. and Janelidze, S. and Ossenkoppele, R. and Kvartsberg, H. and Brinkmalm, A. and Mattsson-Carlgren, N. and Stomrud, E. and Smith, R. and others},
  title   = {{Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2021},
  doi     = {10.1093/brain/awaa395},
  pmid    = {33279949},
  url     = {https://doi.org/10.1093/brain/awaa395}
}

@article{johansson2021-33500386,
  author  = {Johansson, M. and Stomrud, E. and Insel, P. S. and Leuzy, A. and Johansson, P. M. and Smith, R. and Ismail, Z. and Janelidze, S. and others},
  title   = {{Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's disease}},
  journal = {Translational psychiatry},
  year    = {2021},
  doi     = {10.1038/s41398-021-01206-z},
  pmid    = {33500386},
  url     = {https://doi.org/10.1038/s41398-021-01206-z}
}